Senseonics Holdings is a biomedical company specializing in the development and commercialization of innovative glucose monitoring systems for people living with diabetes
The company's flagship product is a long-term implantable continuous glucose monitoring (CGM) device that is designed to provide real-time glucose data to users, enhancing their ability to manage their condition effectively. By combining advanced sensor technology with a commitment to patient care, Senseonics aims to improve the quality of life for individuals with diabetes through more accurate and convenient monitoring options.
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQIDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
